Last reviewed · How we verify
Glucose 25% oral solution — Competitive Intelligence Brief
marketed
Carbohydrate supplement
Endocrinology
Small molecule
Live · refreshed every 30 min
Target snapshot
Glucose 25% oral solution (Glucose 25% oral solution) — Children's & Women's Health Centre of British Columbia. Glucose 25% oral solution provides a concentrated source of glucose to rapidly raise blood sugar levels in hypoglycemic patients.
Comparator set (3 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Glucose 25% oral solution TARGET | Glucose 25% oral solution | Children's & Women's Health Centre of British Columbia | marketed | Carbohydrate supplement | ||
| Glucose solution | Glucose solution | University of Sao Paulo | marketed | Carbohydrate supplement / Nutritional agent | ||
| Simple Syrup | Simple Syrup | Oregon Health and Science University | marketed | Carbohydrate supplement | ||
| glucose 20% | glucose 20% | Universitair Ziekenhuis Brussel | marketed | Carbohydrate supplement; hypertonic dextrose solution |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Carbohydrate supplement class)
- Children's & Women's Health Centre of British Columbia · 1 drug in this class
- Oregon Health and Science University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Glucose 25% oral solution CI watch — RSS
- Glucose 25% oral solution CI watch — Atom
- Glucose 25% oral solution CI watch — JSON
- Glucose 25% oral solution alone — RSS
- Whole Carbohydrate supplement class — RSS
Cite this brief
Drug Landscape (2026). Glucose 25% oral solution — Competitive Intelligence Brief. https://druglandscape.com/ci/glucose-25-oral-solution. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab